351 related articles for article (PubMed ID: 17491523)
1. Multifocal extranodal mucosa-associated lymphoid tissue lymphoma affecting the larynx.
Arndt S; Veelken H; Schmitt-Gräff A; Aschendorff A; Maier W; Richter B
Ann Otol Rhinol Laryngol; 2007 Apr; 116(4):257-61. PubMed ID: 17491523
[TBL] [Abstract][Full Text] [Related]
2. Primary mucosa-associated lymphoid tissue (MALT) lymphoma of the larynx.
Kania RE; Hartl DM; Badoual C; Le Maignan C; Brasnu DF
Head Neck; 2005 Mar; 27(3):258-62. PubMed ID: 15678477
[TBL] [Abstract][Full Text] [Related]
3. Mucosa-associated lymphoid tissue (MALT) lymphoma presenting as subglottic stenosis: single-agent treatment using rituximab.
Bielinski C; Luu HS; Mau T
Otolaryngol Head Neck Surg; 2014 Feb; 150(2):334-5. PubMed ID: 24334958
[No Abstract] [Full Text] [Related]
4. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
[TBL] [Abstract][Full Text] [Related]
5. [Mucosa-associated lymphoid tissue lymphoma of the larynx].
Hua J; Iwaki Y; Inoue M; Takiguchi Y; Ota Y; Hagihara M
Rinsho Ketsueki; 2014 Mar; 55(3):340-4. PubMed ID: 24681938
[TBL] [Abstract][Full Text] [Related]
6. Treatment of gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue with rituximab, cyclophosphamide, vincristine and prednisone.
Aguiar-Bujanda D; Llorca-Mártinez I; Rivero-Vera JC; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Limeres-Gonzalez MA; Cabrera-Marrero JC; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura Grau S; Bohn-Sarmiento U
Hematol Oncol; 2014 Sep; 32(3):139-44. PubMed ID: 24123108
[TBL] [Abstract][Full Text] [Related]
7. [Extranodal non-Hodgkin's lymphoma of MALT-type stage I. A case report].
Kuhnt T; Wollschläger B; Bloching M; Krause U; Dunst J
Strahlenther Onkol; 2003 Jun; 179(6):396-400. PubMed ID: 12789466
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
[TBL] [Abstract][Full Text] [Related]
9. Treatment of localized oral MALT lymphoma by rituximab: a case report.
Yamagata K; Onizawa K; Kojima H; Yoshida H
Oral Maxillofac Surg; 2008 Dec; 12(4):227-30. PubMed ID: 18830723
[TBL] [Abstract][Full Text] [Related]
10. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytic differentiation in MALT lymphomas following treatment with rituximab.
Troch M; Kiesewetter B; Dolak W; Jaeger U; Püspök A; Müllauer L; Chott A; Raderer M
Ann Hematol; 2012 May; 91(5):723-728. PubMed ID: 22186828
[TBL] [Abstract][Full Text] [Related]
12. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients.
Zhang T; Wu Y; Ju H; Meng J; Guo W; Ren G
Cancer Med; 2020 Jan; 9(1):194-203. PubMed ID: 31733094
[TBL] [Abstract][Full Text] [Related]
13. Primary gastric mantle cell lymphoma in a patient with long standing history of Crohn's disease.
Raderer M; Püspök A; Birkner T; Streubel B; Chott A
Leuk Lymphoma; 2004 Jul; 45(7):1459-62. PubMed ID: 15359648
[TBL] [Abstract][Full Text] [Related]
14. Chronic autoimmune thyroiditis (Hashimoto's thyroiditis) in patients with MALT lymphoma.
Troch M; Woehrer S; Streubel B; Weissel M; Hoffmann M; Müllauer L; Chott A; Raderer M
Ann Oncol; 2008 Jul; 19(7):1336-1339. PubMed ID: 18334510
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components.
Li X; Xia B; Guo S; Zhan Z; Zhang L; Zhao D; Wu X; Zhang Y
Ann Hematol; 2013 Jun; 92(6):807-15. PubMed ID: 23417758
[TBL] [Abstract][Full Text] [Related]
16. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Begum S; Sano T; Endo H; Kawamata H; Urakami Y
J Med Invest; 2000 Feb; 47(1-2):36-46. PubMed ID: 10740978
[TBL] [Abstract][Full Text] [Related]
17. Primary marginal zone B-cell lymphoma of the larynx.
Yilmaz M; Ibrahimov M; Mamanov M; Rasidov R; Oktem F
J Craniofac Surg; 2012 Jan; 23(1):e1-2. PubMed ID: 22337445
[TBL] [Abstract][Full Text] [Related]
18. Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond.
Montalban C; Norman F
Expert Rev Anticancer Ther; 2006 Mar; 6(3):361-71. PubMed ID: 16503853
[TBL] [Abstract][Full Text] [Related]
19. Management of gastric mucosa-associated lymphoid tissue lymphoma.
Neumeister P; Troppan K; Raderer M
Dig Dis; 2015; 33(1):11-8. PubMed ID: 25531492
[TBL] [Abstract][Full Text] [Related]
20. Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.
Okamura I; Imai H; Mori K; Ogura K; Isoda A; Mihara K; Matsumoto M; Saito R; Takahashi T; Ikeda T
Int J Hematol; 2015 Jan; 101(1):46-51. PubMed ID: 25378228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
